Trabectedin plus pegylated liposomal doxorubicin in the treatment of patients with partially platinum-sensitive ovarian cancer: current evidence and future perspectives
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Trabectedin plus pegylated liposomal doxorubicin in the treatment of patients with partially platinum-sensitive ovarian cancer: current evidence and future perspectives
Authors
Keywords
-
Journal
ANNALS OF ONCOLOGY
Volume 23, Issue 3, Pages 556-562
Publisher
Oxford University Press (OUP)
Online
2011-07-07
DOI
10.1093/annonc/mdr321
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Predictive impact of DNA repair functionality on clinical outcome of advanced sarcoma patients treated with trabectedin: A retrospective multicentric study
- (2011) P. Schöffski et al. EUROPEAN JOURNAL OF CANCER
- Trabectedin plus pegylated liposomal doxorubicin in relapsed ovarian cancer: outcomes in the partially platinum-sensitive (platinum-free interval 6–12 months) subpopulation of OVA-301 phase III randomized trial
- (2010) A. Poveda et al. ANNALS OF ONCOLOGY
- Trabectedin in ovarian cancer: could we expect more?
- (2010) C. Sessa et al. ANNALS OF ONCOLOGY
- Trabectedin plus pegylated liposomal doxorubicin in relapsed ovarian cancer delays third-line chemotherapy and prolongs the platinum-free interval
- (2010) S. B. Kaye et al. ANNALS OF ONCOLOGY
- Antitumor and Anti-inflammatory Effects of Trabectedin on Human Myxoid Liposarcoma Cells
- (2010) G. Germano et al. CANCER RESEARCH
- Chromosomal instability: A composite phenotype that influences sensitivity to chemotherapy
- (2010) Sarah E. McClelland et al. CELL CYCLE
- A phase II study of combination chemotherapy in early relapsed epithelial ovarian cancer using gemcitabine and pegylated liposomal doxorubicin
- (2010) Mansoor Raza Mirza et al. GYNECOLOGIC ONCOLOGY
- Gemcitabine and Vinorelbine Combination in Platinum-Sensitive Recurrent Ovarian Cancer
- (2010) Annamaria Ferrero et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Phase II Study of Pegylated Liposomal Doxorubicin and Carboplatin in Patients With Platinum-Sensitive and Partially Platinum-Sensitive Metastatic Ovarian Cancer
- (2010) B. L. Rapoport et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Changing the Paradigm in the Treatment of Platinum-Sensitive Recurrent Ovarian Cancer
- (2010) Bradley J. Monk et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Comparison of Studies on Mobile Phone Use and Risk of Tumors
- (2010) Florence Samkange-Zeeb et al. JOURNAL OF CLINICAL ONCOLOGY
- Pegylated Liposomal Doxorubicin and Carboplatin Compared With Paclitaxel and Carboplatin for Patients With Platinum-Sensitive Ovarian Cancer in Late Relapse
- (2010) Eric Pujade-Lauraine et al. JOURNAL OF CLINICAL ONCOLOGY
- Trabectedin Plus Pegylated Liposomal Doxorubicin in Recurrent Ovarian Cancer
- (2010) Bradley J. Monk et al. JOURNAL OF CLINICAL ONCOLOGY
- Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial
- (2010) M William Audeh et al. LANCET
- A Review of Trabectedin (ET-743): A Unique Mechanism of Action
- (2010) Maurizio D'Incalci et al. MOLECULAR CANCER THERAPEUTICS
- Phase II randomized study of trabectedin given as two different every 3 weeks dose schedules (1.5 mg/m2 24 h or 1.3 mg/m2 3 h) to patients with relapsed, platinum-sensitive, advanced ovarian cancer
- (2009) J. M. Del Campo et al. ANNALS OF ONCOLOGY
- Pegylated liposomal doxorubicin combined with carboplatin: A rational treatment choice for advanced ovarian cancer
- (2009) Sandro Pignata et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Efficacy of pegylated liposomal doxorubicin (PLD) plus carboplatin in ovarian cancer patients who recur within six to twelve months: A phase II study
- (2009) Patti Power et al. GYNECOLOGIC ONCOLOGY
- Ovarian cancer in the octogenarian: Does the paradigm of aggressive cytoreductive surgery and chemotherapy still apply?
- (2008) Kathleen N. Moore et al. GYNECOLOGIC ONCOLOGY
- Nonplatinum Topotecan Combinations Versus Topotecan Alone for Recurrent Ovarian Cancer: Results of a Phase III Study of the North-Eastern German Society of Gynecological Oncology Ovarian Cancer Study Group
- (2008) Jalid Sehouli et al. JOURNAL OF CLINICAL ONCOLOGY
- Analysis of the pattern of hypersensitivity reactions in patients receiving carboplatin retreatment for recurrent ovarian cancer
- (2007) A. GADDUCCI et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now